Male gender, younger age, and waist-to-height ratio are independent predictors of prediabetes/type 2 diabetes mellitus (T2DM) among U.S. adolescents, according to a study published online Feb. 25 in ...

A meta-analysis shows GLP-1 RA therapy does not significantly lower vascular dementia events compared with placebo in high-risk patient groups.

Digital Coaching Can Help Control Blood Glucose in T2D A diabetes management system with personalized remote coaching can improve glycemic control to a greater extent than usual care in patients with ...

The association between type 2 diabetes mellitus (T2DM) and spinal degenerative disorders (SDDs) may be method-dependent, according to a study published online July 3 in The Journal of Bone & Joint ...

Researchers have found in a new study that a twelve-week program of combined aerobic and resistance training as well as high-intensity interval training led to meaningful improvements in ...

Ozempic (R) was approved by Health Canada in 2018. Ozempic (R) is indicated for the once-weekly treatment of adult patients with type 2 diabetes mellitus to improve glycemic control.

Nearly 39 million American adults are currently living with diabetes, the latest data shows — and between 90% and 95% of those cases are type 2 diabetes. Type 1 diabetes, although it only makes up 5% ...

In a landmark 14-year study, researchers have found that artificially sweetened drinks raise the risk of developing type 2 diabetes by more than a third, significantly higher than those loaded with ...

Japan: A fixed-dose combination of anagliptin and metformin appears to be safe for patients with type 2 diabetes mellitus (T2DM) who also have moderate renal impairment, according to findings ...

Diabetes affects every part of the body, causing symptoms like fatigue, weight gain, mood changes, and neuropathic pain, among others. These symptoms are not unique to diabetes: They are also common ...